[go: up one dir, main page]

TW200638942A - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
TW200638942A
TW200638942A TW095103848A TW95103848A TW200638942A TW 200638942 A TW200638942 A TW 200638942A TW 095103848 A TW095103848 A TW 095103848A TW 95103848 A TW95103848 A TW 95103848A TW 200638942 A TW200638942 A TW 200638942A
Authority
TW
Taiwan
Prior art keywords
therapeutic agent
acyl
action
coa
prevention
Prior art date
Application number
TW095103848A
Other languages
English (en)
Inventor
Tatsuji Enoki
Yoko Kudo
Katsumi Sugiyama
Hiromu Ohnogi
Hiroaki Sagawa
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of TW200638942A publication Critical patent/TW200638942A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095103848A 2005-02-04 2006-02-03 Therapeutic agent TW200638942A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005029596 2005-02-04

Publications (1)

Publication Number Publication Date
TW200638942A true TW200638942A (en) 2006-11-16

Family

ID=36777131

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095103848A TW200638942A (en) 2005-02-04 2006-02-03 Therapeutic agent

Country Status (5)

Country Link
JP (1) JPWO2006082743A1 (zh)
KR (1) KR20070100829A (zh)
CN (1) CN101115491A (zh)
TW (1) TW200638942A (zh)
WO (1) WO2006082743A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008015950A1 (en) * 2006-08-02 2008-02-07 Takara Bio Inc. Acat inhibitor
US20100249248A1 (en) * 2007-10-24 2010-09-30 Suntory Holdings Limited LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)
JP4608017B1 (ja) * 2010-03-09 2011-01-05 株式会社資生堂 経口摂取用毛穴縮小剤
TW201309313A (zh) * 2011-02-14 2013-03-01 Amino Up Chemical Co Ltd 脂聯素產生促進劑、以及含脂聯素產生促進劑之醫藥組成物、飲食品、及飼料
JP5666053B1 (ja) * 2014-08-01 2015-02-12 株式会社 資生堂 長寿遺伝子発現増強剤
JP7444375B2 (ja) * 2019-12-28 2024-03-06 株式会社 沖縄リサーチセンター 下部尿路症状改善用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60260515A (ja) * 1984-06-07 1985-12-23 Takagi Koichi セセリン化合物を有効成分とする医薬組成物
JPS60260520A (ja) * 1984-06-07 1985-12-23 Takagi Koichi 医薬組成物
WO2004096198A1 (ja) * 2003-05-02 2004-11-11 Takara Bio Inc. 治療剤
JPWO2005074906A1 (ja) * 2004-02-06 2008-01-10 タカラバイオ株式会社 治療剤

Also Published As

Publication number Publication date
CN101115491A (zh) 2008-01-30
KR20070100829A (ko) 2007-10-11
JPWO2006082743A1 (ja) 2008-06-26
WO2006082743A1 (ja) 2006-08-10

Similar Documents

Publication Publication Date Title
TW200637522A (en) Skin treatment articles and methods
MX2008007307A (es) Granulos/capsulas modificados que contienen ingrediente activo.
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
HUS1900037I1 (hu) Orális mikrobaellenes gyógyszerészeti kompozíciók
WO2009031606A1 (ja) 関節炎治療及び予防剤
TNSN07240A1 (en) Compounds for flaviviridae treatment
WO2007140191A3 (en) Glucose transport inhibitors and methods of use
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2009078447A1 (ja) 抗ノロウイルス剤、抗インフルエンザウイルス剤、およびこれらを用いた抗ウイルス処理方法
MY145074A (en) Thiazolidin-4-one derivatives
MX2009003911A (es) Formulaciones de liberacion inmediata, mejoradas de topiramato.
MX339116B (es) Tratamiento de esclerosis tuberosa.
MY162076A (en) Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
WO2004028475A3 (en) Glycosylceramide analogues
WO2008029237A3 (en) Combination therapies for rheumatoid arthritis
WO2010134827A9 (en) Extended acting oxygen generating composition for treating microbial infections
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2008097364A3 (en) Use of oritavancin for prevention and treatment of anthrax
TW200638942A (en) Therapeutic agent
WO2004087045A3 (en) Devices, methods, and compositions to prevent restenosis
WO2009090085A8 (en) Abnormal intraocular pressure treatment